Starting from April, pharmaceutical companies that have not submitted a letter of trust will not be able to participate in new bids or online appeals!

In accordance with the requirements of the National Medical Insurance Administration, starting from April 1st, for pharmaceutical companies that have not submitted a "Pharmaceutical Enterprise Price and Marketing Behavior Credit Commitment", the provincial centralized procurement agencies will no longer accept their new bids or online appeals.

Starting from June 1, the pharmaceutical products that have won the bid or are listed on the Internet will be removed from the Internet if there are other companies that guarantee the supply or have alternatives to meet clinical needs.

According to known information, this requirement originated from the "Notice on Accelerating the Implementation of the Medical Price and Recruitment Credit Evaluation System" issued by the National Medical Insurance Administration last year.

The original text is as follows:

The Office of the National Medical Security Administration on Accelerating the Implementation of Medical Prices

And the notice of the recruitment credit evaluation system

Medical Insurance Office Issue (2020) No.

The medical security bureaus of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps, and all provincial-level centralized procurement agencies for medicines and medical consumables:

In order to implement the "Guiding Opinions of the National Medical Security Administration on Establishing a Medical Price and Recruitment Credit Evaluation System" (Yibaofa [2020] No.

1.

2.

3.

4.

Fifth, make substantial progress as soon as possible.

6.

National Medical Security Administration Office

December 24, 2020